Jonathan Gillis, Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 73,691 shares at $8.08 ($595K) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Open-market sale of $595k MPLT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |